Skip to main
IMAX
IMAX logo

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp demonstrated significant financial growth in Q3, reporting a Gross Box Office of $367.0 million, reflecting a 50% year-over-year increase, and projecting a Gross Box Office of $345 million for Q4, which would mark a robust 66% year-over-year growth, culminating in an estimated $1.29 billion for the year, up 40.5% year-over-year. The company's consolidated Gross Margins expanded to 63.1%, with Content Solutions showing a notable improvement to 71.2%, driven by increased installations and higher box office revenues. Furthermore, both net revenue and EBITDA experienced healthy growth, with net revenue rising to $105 million (+17%) and EBITDA reaching a street high of $50 million (+29%), supported by strong performances across key regions including North America and China.

Bears say

The analysis indicates a negative outlook for Imax Corp, primarily due to declining revenue expectations, with projected figures of $122.2 million and $59.9 million, down from $124.2 million and $63.6 million in the previous period. Increased operating expenses in the form of higher selling, general, and administrative costs, along with research and development expenditures, further underscore financial strain, as these expenses were notably lower in the year-ago period due to one-time items. Additionally, challenges within the exhibition industry, including a decline in the Chinese market and potential reductions in audience demand for films, pose significant risks to box office growth and the overall performance of the company.

IMAX (IMAX) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 9 analysts, IMAX (IMAX) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.